MUTYH base excision repair ovarian cancer predictive biomarker

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
06 Jan 2021
Historique:
received: 06 12 2020
revised: 28 12 2020
accepted: 05 01 2021
entrez: 9 1 2021
pubmed: 10 1 2021
medline: 10 1 2021
Statut: epublish

Résumé

Approximately 18% of ovarian cancers have an underlying genetic predisposition and many of the genetic alterations have become intervention and therapy targets. Although mutations in MutY homolog (

Identifiants

pubmed: 33419231
pii: diagnostics11010084
doi: 10.3390/diagnostics11010084
pmc: PMC7825630
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Clin Cancer Res. 2017 Jul 15;23(14):3628-3637
pubmed: 28143870
J Natl Cancer Inst. 1983 Oct;71(4):717-21
pubmed: 6578367
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
J Pathol. 2016 Jan;238(1):98-108
pubmed: 26414517
J Clin Oncol. 2009 Mar 10;27(8):1250-6
pubmed: 19204208
Fam Cancer. 2010 Dec;9(4):589-94
pubmed: 20640893
Lancet Oncol. 2007 Jan;8(1):26-34
pubmed: 17196508
J Biol Chem. 2002 Mar 29;277(13):11135-42
pubmed: 11801590
J Clin Lab Anal. 2007;21(6):372-4
pubmed: 18022921
Cancers (Basel). 2018 Dec 04;10(12):
pubmed: 30518089
N Engl J Med. 2009 Jul 9;361(2):170-7
pubmed: 19587342
Oncol Rep. 2019 Dec;42(6):2716-2727
pubmed: 31578574
Medicines (Basel). 2018 Feb 01;5(1):
pubmed: 29389895
Gut. 2012 May;61(5):734-8
pubmed: 21846783
Hum Mutat. 2010 Feb;31(2):159-66
pubmed: 19953527
BMC Cancer. 2009 Jun 15;9:184
pubmed: 19527492
BMB Rep. 2011 May;44(5):352-7
pubmed: 21615992
Gynecol Oncol. 2015 Apr;137(1):86-92
pubmed: 25622547
Br J Cancer. 2008 Dec 16;99(12):2020-8
pubmed: 19018267
J Clin Oncol. 2008 Apr 1;26(10):1626-34
pubmed: 18316791
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Br J Cancer. 2009 Aug 4;101(3):441-51
pubmed: 19623177
Lancet Oncol. 2013 Jan;14(1):38-47
pubmed: 23200175
Br J Pharmacol. 2014 Apr;171(8):2000-16
pubmed: 24684389
J Mol Biol. 2005 Nov 11;353(5):980-9
pubmed: 16216273
Cancer. 2003 May 1;97(9):2187-95
pubmed: 12712470
Eur J Hum Genet. 2014 Nov;22(11):1334-7
pubmed: 24518836
Am J Surg Pathol. 2006 Feb;30(2):230-6
pubmed: 16434898
EMBO J. 2003 Feb 3;22(3):713-23
pubmed: 12554671
Toxicology. 2006 Feb 15;219(1-3):133-41
pubmed: 16343728
DNA Repair (Amst). 2019 Aug;80:16-25
pubmed: 31203172
Gynecol Oncol. 2018 Apr;149(1):146-154
pubmed: 29496294
Cancer Discov. 2017 Jul;7(7):675-693
pubmed: 28630051
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):249-54
pubmed: 25352525
Obstet Gynecol. 2012 Aug;120(2 Pt 1):235-40
pubmed: 22776961
Environ Mol Mutagen. 2013 Jun;54(5):327-37
pubmed: 23677513
Nucleic Acids Res. 2004 Jun 15;32(10):3198-211
pubmed: 15199168
Sci Rep. 2016 Jan 21;6:18658
pubmed: 26791325
J Biol Chem. 2005 Jan 7;280(1):408-17
pubmed: 15533944
Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3
pubmed: 5279523
Int J Mol Cell Med. 2012 Spring;1(2):75-87
pubmed: 24551762
Invest New Drugs. 2020 Jun;38(3):894-898
pubmed: 31377904
Gastroenterology. 2009 Dec;137(6):1976-85.e1-10
pubmed: 19732775
Nat Genet. 2002 Feb;30(2):227-32
pubmed: 11818965
Mol Cell Biol. 2001 Jul;21(13):4129-39
pubmed: 11390642
JAMA. 2018 Jun 19;319(23):2401-2409
pubmed: 29922827
Ann Oncol. 2019 Jul 1;30(7):1071-1079
pubmed: 31090900
Am J Pathol. 2016 Apr;186(4):733-47
pubmed: 27012190
CA Cancer J Clin. 2018 May;68(3):217-231
pubmed: 29485237
J Pathol. 2018 Nov;246(3):344-351
pubmed: 30043522
Cell Mol Life Sci. 2013 Nov;70(21):4009-21
pubmed: 23508805
Mol Cell. 2017 Nov 16;68(4):797-807.e7
pubmed: 29149600
Cold Spring Harb Mol Case Stud. 2019 Apr 1;5(2):
pubmed: 30833417
Int J Cancer. 2017 Oct 1;141(7):1365-1380
pubmed: 28577310
JAMA Oncol. 2018 Apr 01;4(4):516-521
pubmed: 29346467
J Natl Compr Canc Netw. 2021 Jan 06;19(1):77-102
pubmed: 33406487
Cancer Res. 1996 Jul 1;56(13):3087-90
pubmed: 8674066
Science. 2008 Mar 7;319(5868):1352-5
pubmed: 18323444
EBioMedicine. 2017 Jun;20:39-49
pubmed: 28551381
Oncogenesis. 2014 Oct 13;3:e121
pubmed: 25310643
JAMA Oncol. 2016 Apr;2(4):482-90
pubmed: 26720728
JAMA Oncol. 2021 Feb 01;7(2):230-237
pubmed: 33126242
JCO Oncol Pract. 2020 Aug;16(8):e835-e838
pubmed: 32074015
Cancer Epidemiol Biomarkers Prev. 2017 Mar;26(3):404-412
pubmed: 27799157
Cancers (Basel). 2020 Mar 20;12(3):
pubmed: 32245016
Lancet. 1979 Jul 28;2(8135):170-3
pubmed: 89281
DNA Repair (Amst). 2013 Dec;12(12):1043-52
pubmed: 24209961
Gut. 2018 Jul;67(7):1306-1316
pubmed: 28754778
Cancer Epidemiol Biomarkers Prev. 2020 Jun;29(6):1095-1106
pubmed: 32169997
Int J Cancer. 2016 Oct 1;139(7):1557-63
pubmed: 27194394
Gynecol Oncol. 2011 May 1;121(2):353-7
pubmed: 21324516
Nature. 2008 Feb 28;451(7182):1116-20
pubmed: 18264087
N Engl J Med. 2020 May 28;382(22):2091-2102
pubmed: 32343890
Genes Dev. 2008 Oct 1;22(19):2621-6
pubmed: 18805990
Mol Cancer Ther. 2008 Jun;7(6):1440-9
pubmed: 18566216
J Pathol. 2007 Jan;211(1):26-35
pubmed: 17117391
DNA Repair (Amst). 2007 Mar 1;6(3):274-9
pubmed: 17161978
Am Soc Clin Oncol Educ Book. 2016;35:e247-57
pubmed: 27249730
Oncogene. 2012 Apr 12;31(15):1869-83
pubmed: 21892204
Fam Cancer. 2011 Mar;10(1):1-9
pubmed: 21061173
EMBO J. 2008 Jan 23;27(2):421-32
pubmed: 18188152
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
J Toxicol Environ Health A. 2012;75(13-15):920-33
pubmed: 22788377
J Med Genet. 2016 Jul;53(7):465-71
pubmed: 26928436

Auteurs

Megan L Hutchcraft (ML)

Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Kentucky Markey Cancer Center, 800 Rose Street, Lexington, KY 40536-0263, USA.

Holly H Gallion (HH)

Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Kentucky Markey Cancer Center, 800 Rose Street, Lexington, KY 40536-0263, USA.

Jill M Kolesar (JM)

Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Kentucky Markey Cancer Center, 800 Rose Street, Lexington, KY 40536-0263, USA.
Department of Pharmacy Practice & Science, University of Kentucky College of Pharmacy, 567 Todd Building, 789 South Limestone Street, Lexington, KY 40539-0596, USA.

Classifications MeSH